ArticleNature genetics2021
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Open access · hybridAbstract readPublished Erratum
In one paragraph
Article in Nature genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Article
- Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates.Oncotarget · 2022Review
Corrections and comments
- Erratum for
Authors and funding
64 authors at 17 institutions in 9 countries.
Xing Yi Woo *The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0002-5980-4383
Jessica Giordano *Department of Oncology, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0003-0204-8158
Anuj SrivastavaThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Zi-Ming ZhaoThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Michael W LloydThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA.
Roebi de BruijnNetherlands Cancer Institute, Amsterdam, the Netherlands.
Yun-Suhk SuhCollege of Medicine, Seoul National University, Seoul, Republic of Korea.
Rajesh PatidarFrederick National Laboratory for Cancer Research, Frederick, MD, USA.
Li ChenFrederick National Laboratory for Cancer Research, Frederick, MD, USA.
Sandra SchererDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Matthew H BaileyDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Chieh-Hsiang YangDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Emilio Cortes-SanchezDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Yuanxin XiDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jing WangDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-5398-0802
Jayamanna WickramasingheThe Wistar Institute, Philadelphia, PA, USA.
Andrew V KossenkovThe Wistar Institute, Philadelphia, PA, USA.
Vito W RebeccaThe Wistar Institute, Philadelphia, PA, USA.
Hua SunDepartment of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
R Jay MashlDepartment of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Sherri R DaviesDepartment of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-7141-8354
Ryan JeonSeven Bridges Genomics, Charlestown, MA, USA.
Christian FrechSeven Bridges Genomics, Charlestown, MA, USA.
Jelena RandjelovicSeven Bridges Genomics, Charlestown, MA, USA.
Jacqueline RosainsSeven Bridges Genomics, Charlestown, MA, USA.
Francesco GalimiDepartment of Oncology, University of Turin, Turin, Italy.
Andrea BertottiDepartment of Oncology, University of Turin, Turin, Italy.
Adam LaffertyDepartment of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Alice C O'FarrellDepartment of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID http://orcid.org/0000-0002-6732-2966
Elodie ModaveCenter for Cancer Biology, VIB, Leuven, Belgium.
Diether LambrechtsCenter for Cancer Biology, VIB, Leuven, Belgium.ORCID http://orcid.org/0000-0002-3429-302X
Petra Ter BruggeNetherlands Cancer Institute, Amsterdam, the Netherlands.
Violeta SerraVall d´Hebron Institute of Oncology, Barcelona, Spain.ORCID http://orcid.org/0000-0001-6620-1065
Elisabetta MarangoniDepartment of Translational Research, Institut Curie, PSL Research University, Paris, France.ORCID http://orcid.org/0000-0002-3337-6448
Rania El BottyDepartment of Translational Research, Institut Curie, PSL Research University, Paris, France.
Hyunsoo KimThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Jong-Il KimCollege of Medicine, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-7240-3744
Han-Kwang YangCollege of Medicine, Seoul National University, Seoul, Republic of Korea.
Charles LeeThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Dennis A DeanSeven Bridges Genomics, Charlestown, MA, USA.ORCID http://orcid.org/0000-0002-7621-9717
Brandi Davis-DusenberySeven Bridges Genomics, Charlestown, MA, USA.
Yvonne A EvrardFrederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-3475-4850
James H DoroshowDivision of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Alana L WelmDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0002-1412-1351
Bryan E WelmDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Michael T LewisLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Bingliang FangDepartment of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jack A RothDepartment of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8955-1313
Funda Meric-BernstamDepartment of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Meenhard HerlynThe Wistar Institute, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0839-0739
Michael A DaviesDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0977-0912
Li DingDepartment of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Shunqiang LiDepartment of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Ramaswamy GovindanDepartment of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Claudio IsellaDepartment of Oncology, University of Turin, Turin, Italy.
Jeffrey A MoscowInvestigational Drug Branch, National Cancer Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-0479-1693
Livio TrusolinoDepartment of Oncology, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0002-6379-3365
Annette T ByrneDepartment of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Jos JonkersNetherlands Cancer Institute, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-9264-9792
Carol J BultThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA.
Enzo MedicoDepartment of Oncology, University of Turin, Turin, Italy. enzo.medico@unito.it.ORCID http://orcid.org/0000-0002-3917-2438
Jeffrey H ChuangThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. jeff.chuang@jax.org.ORCID http://orcid.org/0000-0002-3298-2358
PDXNET Consortium
EurOPDX Consortium
Jackson Laboratory · USCandiolo Cancer Institute · ITSeven Bridges Genomics (United States) · USThe University of Texas MD Anderson Cancer Center · USUniversity of Utah · USWashington University in St. Louis · USThe Wistar Institute · USFrederick National Laboratory for Cancer Research · USRoyal College of Surgeons in Ireland · IESeoul National University · KRThe Netherlands Cancer Institute · NLNational Cancer Institute · USUniversité Paris Sciences et Lettres · FRVIB-KU Leuven Center for Cancer Biology · BEBaylor College of Medicine · USEwha Womans University · KRVall d'Hebron Institute of Oncology · ES
Funding
Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9MPhase 01 Clinical TrialsZIABC011078 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DOROSHOW, JAMES · 2009 to 2025
$9.0MUniversity of Texas PDX Development and Trial CenterU54CA224065 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MERIC-BERNSTAM, FUNDA, ROTH, JACK · 2017 to 2022
$7.7MNCI NIH HHS P30 CA034196NCI NIH HHS U54 CA224065
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.